Literature DB >> 19424703

[Keratomycosis: diagnosis and therapy].

W Behrens-Baumann1.   

Abstract

Diagnosis of fungal keratitis is only straightforward if it presents in its typical form with pyramidal-shaped hypopyon, prominent geographical corneal infiltration and satellites. However, in contact-lens wearers clinical presentation is untypical at early infection. Corneal debridement is therefore necessary, which simultaneously facilitates penetration of the antimycotic into the corneal stroma. At present, voriconazole is the medication of choice, if not changed after microbiological diagnosis to a specifically more potent substance - e.g. posaconazole or caspofungin. Amphotericin B may be used for repeated intracameral or intravitreal injection. Simultaneous application of steroids is useful.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19424703     DOI: 10.1007/s00347-009-1925-1

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  78 in total

1.  Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

Authors:  Andrew J Ullmann; Jeffrey H Lipton; David H Vesole; Pranatharthi Chandrasekar; Amelia Langston; Stefano R Tarantolo; Hildegard Greinix; Wellington Morais de Azevedo; Vijay Reddy; Navdeep Boparai; Lisa Pedicone; Hernando Patino; Simon Durrant
Journal:  N Engl J Med       Date:  2007-01-25       Impact factor: 91.245

2.  Influence of corticosteroid on experimentally induced keratomycosis.

Authors:  D M O'Day; W A Ray; W S Head; R D Robinson; T E Williams
Journal:  Arch Ophthalmol       Date:  1991-11

Review 3.  International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections.

Authors:  J E Edwards; G P Bodey; R A Bowden; T Büchner; B E de Pauw; S G Filler; M A Ghannoum; M Glauser; R Herbrecht; C A Kauffman; S Kohno; P Martino; F Meunier; T Mori; M A Pfaller; J H Rex; T R Rogers; R H Rubin; J Solomkin; C Viscoli; T J Walsh; M White
Journal:  Clin Infect Dis       Date:  1997-07       Impact factor: 9.079

Review 4.  Pharmacologic management of keratomycoses.

Authors:  K J Johns; D M O'Day
Journal:  Surv Ophthalmol       Date:  1988 Nov-Dec       Impact factor: 6.048

5.  Pimaricin therapy of cephalosporium and fusarium keratitis.

Authors:  E Newmark; A C Ellison; H E Kaufman
Journal:  Am J Ophthalmol       Date:  1970-03       Impact factor: 5.258

6.  [Fungal growth on soft contact lenses (author's transl)].

Authors:  T Neuhann; K Blassmann; H W Roth
Journal:  Klin Monbl Augenheilkd       Date:  1978-11       Impact factor: 0.700

7.  Fusarium oxysporum endophthalmitis.

Authors:  J J Rowsey; T E Acers; D L Smith; J A Mohr; D L Newsom; J Rodriguez
Journal:  Arch Ophthalmol       Date:  1979-01

8.  A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

Authors:  John H Rex; Peter G Pappas; Adolf W Karchmer; Jack Sobel; John E Edwards; Susan Hadley; Corstiaan Brass; Jose A Vazquez; Stanley W Chapman; Harold W Horowitz; Marcus Zervos; David McKinsey; Jeannette Lee; Timothy Babinchak; Robert W Bradsher; John D Cleary; David M Cohen; Larry Danziger; Mitchell Goldman; Jesse Goodman; Eileen Hilton; Newton E Hyslop; Daniel H Kett; Jon Lutz; Robert H Rubin; W Michael Scheld; Mindy Schuster; Bryan Simmons; David K Stein; Ronald G Washburn; Linda Mautner; Teng-Chiao Chu; Helene Panzer; Rebecca B Rosenstein; Jenia Booth
Journal:  Clin Infect Dis       Date:  2003-05-08       Impact factor: 9.079

Review 9.  Posaconazole for paediatric patients: status of development and future perspectives.

Authors:  Andreas H Groll; Thomas Lehrnbecher
Journal:  Mycoses       Date:  2008-09       Impact factor: 4.377

10.  Fluconazole in the treatment of candida albicans endophthalmitis.

Authors:  S F Urbak; T Degn
Journal:  Acta Ophthalmol (Copenh)       Date:  1992-08
View more
  8 in total

1.  [The German Acanthamoeba keratitis register: Initial results of a multicenter study].

Authors:  L Daas; N Szentmáry; T Eppig; A Langenbucher; A Hasenfus; M Roth; M Saeger; B Nölle; B Lippmann; D Böhringer; T Reinhard; C Kelbsch; E Messmer; U Pleyer; S Roters; A Zhivov; K Engelmann; J Schrecker; L Zumhagen; H Thieme; R Darawsha; T Meyer-Ter-Vehn; B Dick; I Görsch; M Hermel; M Kohlhaas; B Seitz
Journal:  Ophthalmologe       Date:  2015-09       Impact factor: 1.059

2.  [Rational antibiotic therapy in ophthalmology].

Authors:  W Behrens-Baumann; U Frank; T Ness
Journal:  Ophthalmologe       Date:  2010-04       Impact factor: 1.059

3.  [Persistent contact lens-associated keratitis].

Authors:  A Klingenstein; W J Mayer; J Rueping; C Miller; A Kampik; H Mino De Kaspar
Journal:  Ophthalmologe       Date:  2011-12       Impact factor: 1.059

4.  [Adjunctive corticosteroids for antimicrobial treatment].

Authors:  W Behrens-Baumann
Journal:  Ophthalmologe       Date:  2016-11       Impact factor: 1.059

5.  [Prolonged topical natamycin 5 % therapy before and after keratoplasty for Fusarium keratitis].

Authors:  N Cvetkova; J Köstler; P Prahs; H Helbig; T Dietrich-Ntoukas
Journal:  Ophthalmologe       Date:  2016-05       Impact factor: 1.059

6.  [Successful treatment of Fusarium-associated keratitis with multiresistant pathogen and multimorbid patient].

Authors:  M Alnawaiseh; M R R Böhm; E A Idelevich; K Becker; S Grewe; U H Grenzebach; N Eter
Journal:  Ophthalmologe       Date:  2014-03       Impact factor: 1.059

7.  [Iris tumor of unknown origin].

Authors:  J Rueping; A Klingenstein; J Wagener; A Kampik; D Kook
Journal:  Ophthalmologe       Date:  2013-12       Impact factor: 1.059

8.  [Confocal microscopy for the diagnostics of fungal keratitis].

Authors:  L Daas; A Viestenz; M Bischoff; A Hasenfus; B Seitz
Journal:  Ophthalmologe       Date:  2016-09       Impact factor: 1.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.